BidSonarBidSonar
ContractsGrantsOrganisationsSectors
BidSonarBidSonar·Built by Hypership
SourcesPrivacyTermsCookies

BidSonar is an independent index of public-sector opportunities. We aggregate data from official sources and are not affiliated with any procurement body. Data is licensed under the Open Government Licence v3.0 and the EU TED reuse notice.

    ContractsGermany – Pharmaceutical Agreements
    Open tender

    Germany – Pharmaceutical Agreements

    Tender closes
    439d
    5 Nov 2027 · in 15 months

    This contract opportunity involves establishing non-exclusive discount agreements for various active substances and combinations under Section 130a (8) of the Social Code Book V (SGB V) through an Open House procedure. Suppliers are invited to submit proposals for the supply of pharmaceuticals, whic

    🇩🇪GermanyPublished 23 Nov 2025· 9 months agoviaTED
    Tender closes
    439d
    5 Nov 2027 · in 15 months

    Decision brief

    4 fields
    • Contract value
      Not disclosed
      Source did not declare a figure
    • Tender closes
      5 Nov 2027
      439 days left
    • Sector
      Healthcare & Medical
      Browse related listings
    • Location
      🇩🇪Germany

    Lifecycle

    Open

    439 days left to bid. Opened 9 months ago, deadline 5 Nov 2027.

    23 Nov 2025Today5 Nov 2027

    Brief

    This contract opportunity involves establishing non-exclusive discount agreements for various active substances and combinations under Section 130a (8) of the Social Code Book V (SGB V) through an Open House procedure. Suppliers are invited to submit proposals for the supply of pharmaceuticals, which may include a range of medications. The agreements will allow for ongoing participation, providing flexibility for suppliers to join at any time. The aim is to enhance access to essential medicines while ensuring competitive pricing.

    Open in Healthcare & Medical

    4 open listingsView all →
    Healthcare & Medical🇬🇧United Kingdom

    Early Cancer Diagnostic Technologies Development Programme

    Innovate UK is investing up to £25.4 million to help develop and test early cancer diagnostic technologies, particularly for less common cancers, with projects costing £1.5-£4 million over 24-36 months.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Clinical Validation of Early Cancer Diagnostic Technologies

    Innovate UK is offering up to £25.4 million to fund collaborative projects that clinically validate innovative early cancer diagnostic technologies and devices led by UK organisations including at least one SME.

    est.£25,400,000
    Published 1 Sept 2026
    Healthcare & Medical🇬🇧United Kingdom

    Echocardiography Services - Backlog Reduction Contract

    GHFT seeks echocardiography service providers to reduce diagnostic waiting times through a two-year contract with optional extensions starting April 2027.

    est.£2,000,000GLOUCESTERSHIRE HOSPITALS NHS FOUNDATION TRUST
    Published 24 Aug 2026
    OpenHealthcare & Medical🇬🇧United Kingdom

    St Helens Healthy Child Programme Soft Market Testing (0-19 Years)

    St Helens Council is soft market testing for providers to deliver the Healthy Child Programme (health visiting and school nursing for ages 0-19), with an anticipated annual value of £4.2m over 5 years plus optional extensions.

    £29,348,907indicativeSt Helens Council
    Published 24 Aug 2026
    Take action
    View tender on sourceTED

    Full notice and submission process on the publisher's site

    Publisher
    Publications Office of the European Union
    Licence
    EU 2011/833/EU + TED reuse notice
    Source
    ted.europa.eu
    Record ID
    779023-2025
    AN
    Buyer
    AOK NORDOST THE HEALTH FUND
    Sector
    Healthcare & Medical